TRENDING :  Market Movers  |  Top 50   AAPL (0%)    TSLA (0%)    TVIX (0%)    RIOT (0%)    QURE (0%)    QQQ (0%)    QCOM (0%)    PSTG (0%)    PEI (0%)    PAH (0%)    MCD (0%)    KO (0%)    JPM (0%)    IVC (0%)    IMDZ (0%)    GS (0%)    GOOGL (0%)    FDX (0%)    FCEL (0%)    FB (0%)    EA (0%)    CRM (0%)    CBS (0%)    BILI (0%)    BIDU (0%)

 DGX - Quest Diagnostics Incorporated

$87.81 [0][0%]

Next Earnings

4/18/2019

BMO

Recommend
Trade Idea »



ANALYST RATINGS

Quarterly Rating Chart
Rating

2


1=Strong Buy, 2=Buy, 3=Hold, 4=Underperform, 5=Sell
Price Targets
High $101.00
Low $90.00
Average $93.67
Current $87.81

CompanyAnalyst NamePT ActionActionRatingTargetDate
Credit SuisseA.J. RiceLowersMaintainsStrong Buy$101.0002/19/19
UBSAnnouncesInitiates Coverage OnHold$90.0001/17/19
Goldman SachsPatrick DonnellyLowersDowngradesHold$90.0011/30/18
*Last 90 days

OPEN RECOMMENDATIONS

No recommendations found.


This list is limited to recommendations made in last 7 days only. Subscribe to a service to see all their recommendations.

TRADERS TRACKING $DGX

TRENDING ARTICLES



Quest Diagnostics Inc (DGX) Q4 2018 Earnings Conference Call Transcript

02/14/19
Quest Diagnostics Inc NYSE DGX Image source The Motley Fool Q4 160 2018 Earnings Conference Call Feb 14 2019 8 30 a m ET Contents Prepared Remarks Questions and Answers Call Participants Prepared

Quest Diagnostics (DGX) Q4 Earnings in Line, Margins Down

02/14/19
Quest Diagnostics Incorporated s DGX fourth quarter 2018 adjusted earnings per share EPS of 1 36 were on par with the Zacks Consensus Estimate Adjusted earnings declined 1 4 from the year ago number Reported EPS came in at 92 cents reflecting a 49 5 decline from the year ago

Quest Diagnostics (DGX) Q4 Earnings Meet Estimates

02/14/19
Quest Diagnostics DGX came out with quarterly earnings of 1 36 per share in line with the Zacks Consensus Estimate This compares to earnings of 1 38 per share a year ago These figures are adjusted for non recurring items A quarter ago it was expected that this medical laboratory

Look Under The Hood: SCIU Has 10% Upside

02/14/19
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For

Can M&A Activity Drive Quest Diagnostics (DGX) Q4 Earnings?

02/11/19
Quest Diagnostics Incorporated DGX is scheduled to report fourth quarter 2018 earnings before the opening bell on Feb 14 In the las t report ed quarter the company s earnings were in line with the Zacks Consensus Estimate However average trailing four quarter beat was delivered at 0

Earnings Preview: Quest Diagnostics (DGX) Q4 Earnings Expected to Decline

02/07/19
Wall Street expects a year over year decline in earnings on lower revenues when Quest Diagnostics DGX reports results for the quarter ended December 2018 While this widely known consensus outlook is important in gauging the company s earnings picture a powerful factor that could impact